HUN

Huntsman Corporation 2004 10-K Filing Summary

Business Context and Reporting Period

This filing covers the fiscal year ended December 31, 2004, for Huntsman Corporation, a Delaware corporation formed in 2004 to hold the global chemical businesses of the Huntsman family. The company operates through six segments: Polyurethanes, Advanced Materials, Performance Products, Pigments, Polymers, and Base Chemicals. It is a leading global producer of differentiated and commodity chemical products, operating 62 manufacturing facilities in 22 countries with approximately 11,300 employees.

Recent Developments: On February 16, 2005, the company completed an Initial Public Offering (IPO) of common and mandatory convertible preferred stock, raising approximately $1.5 billion in net proceeds. These proceeds were immediately utilized to repay significant subsidiary indebtedness and redeem various senior notes.

Key Financial Metrics (Year Ended Dec 31, 2004)

Note: 2003 figures are presented on a pro forma basis to reflect the consolidation of HIH (May 2003) and Advanced Materials (June 2003) for the full year, providing a more meaningful comparison.

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 24% year-over-year (pro forma), driven by higher average selling prices across all segments and increased sales volumes in Polyurethanes, Advanced Materials, Pigments, Polymers, and Base Chemicals.
• Profitability Improvement: Operating income rose 91% to $400.4 million. Gross profit increased 40% as selling price increases outpaced raw material and energy cost increases.
• Restructuring Costs: Restructuring and plant closing costs surged to $299.3 million (up from $55.0 million pro forma in 2003). Significant charges were recorded in the Pigments ($123.3 million) and Performance Products ($97.5 million) segments related to facility closures and workforce reductions.
• Segment Performance:
  • Polyurethanes: EBITDA increased 56% to $364.0 million, driven by MDI demand and pricing.
  • Advanced Materials: EBITDA surged 286% to $186.1 million due to margin expansion and lower reorganization costs.
  • Pigments: EBITDA turned negative at $(30.0) million (from $105.4 million income) primarily due to $123.3 million in restructuring charges and $15.1 million in legal settlement costs related to titanium dioxide discoloration claims.
  • Base Chemicals: EBITDA increased 285% to $276.2 million due to higher contribution margins.

Guidance, Outlook, Risks, and Unusual Items

• Debt Reduction Strategy: The company expects to report a loss on early extinguishment of debt of approximately $235 million in Q1 2005 following the use of IPO proceeds to redeem HMP Senior Discount Notes, HIH Senior Discount Notes, and HLLC Senior Secured Notes.
• Capital Expenditures: The company expects to spend approximately $400 million on capital projects in 2005, including $80 million for a new LDPE facility in Wilton, U.K., and investments in Chinese MDI joint ventures.
• Key Risks:
  • MTBE Regulation: Significant regulatory and legal risks exist regarding the use of MTBE as a gasoline additive. Bans in California, New York, and Connecticut, and potential federal phase-outs, could materially reduce revenues or increase costs.
  • Internal Controls: Auditors identified material weaknesses in internal controls regarding financial reporting processes and data aggregation, leading to restatements of prior periods. Management is implementing remediation plans.
  • Commodity Cyclicality: Profitability in Polymers and Base Chemicals remains cyclical and sensitive to raw material costs and global economic conditions.
  • Legal Proceedings: Ongoing litigation regarding titanium dioxide discoloration claims and environmental remediation liabilities (e.g., North Maybe Canyon site) pose potential financial risks, though management does not currently expect material impact.

Investor Verification Checklist

• Debt Repayment Execution: Verify the successful redemption of the specific senior notes (HMP, HIH, HLLC) using IPO proceeds and the resulting reduction in interest expense.
• Restructuring Progress: Monitor the execution of the $299.3 million restructuring plan, specifically the closure of the Whitehaven, U.K. surfactants facility and the idling of 10% of titanium dioxide capacity, to ensure expected cost savings are realized.
• MTBE Exposure: Assess the impact of ongoing MTBE bans and litigation on the Polyurethanes segment's cash flow and the potential capital expenditure required to convert TBA production to alternative products.
• Internal Control Remediation: Review subsequent filings (10-Q) for confirmation that the material weaknesses in financial reporting identified by auditors have been remediated.
• Joint Venture Funding: Track the funding requirements and progress of the Chinese MDI joint ventures, which represent significant future capacity but require ongoing equity investment.